General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Merck & Co., Inc.(MODEST), Whiteswell(MODEST), Novartis Corporation(MODEST), Abiomed(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Astra Zeneca(MODEST) OTHER FINANCIAL BENEFIT: Zoll(MODEST), Bioventrix(NONE)

View Full Disclosure